Condition
Hypothalamic Neoplasms
Total Trials
3
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting1
Completed1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07809178Not Yet Recruiting
China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm
NCT07396896Not ApplicableRecruiting
KETO-TUMOR: a Study on Brain Tumors and Central Obesity
NCT03137615CompletedPrimary
The Cardiovascular Changes Associated With Septal Local Anaesthesia
Showing all 3 trials